# XENOVIEW
> **NDA214375** · New Drug Application · Sponsor: POLAREAN · Approved 2022-12-23
## Drug
- **FDA Application Number:** NDA214375
- **Application type:** New Drug Application
- **Brand name:** XENOVIEW
- **Generic name:** XENON XE 129 HYPERPOLARIZED
- **Active ingredients:** XENON XE-129 HYPERPOLARIZED
- **Dosage form:** GAS
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** POLAREAN
- **Manufacturer:** Polarean, Inc.
- **First approval:** 2022-12-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214375)
---
*MORVS · CC0 1.0*